Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arixtra in Heparin-Induced Thrombocytopenia
NCT00673439Phase 2Terminated
- Sponsor
- University of Louisville
- Start
- Nov 2007
- Primary completion
- Sep 2011
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of fondaparinux in heparin-induced thrombocytopenia (HIT), sponsored by University of Louisville. Started Nov 2007; status: terminated.
02
Drugs
fondaparinux
03
Conditions
heparin-induced thrombocytopenia (HIT)
Beyond the preview
Go deeper on NCT00673439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673439.